These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24050277)

  • 1. Technology combination to address GPCR allosteric modulator drug-discovery pitfalls.
    Schann S; Bouvier M; Neuville P
    Drug Discov Today Technol; 2013; 10(2):e261-7. PubMed ID: 24050277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors.
    Milligan G
    Eur J Pharm Sci; 2004 Mar; 21(4):397-405. PubMed ID: 14998570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of GPCR dimerization using acceptor photobleaching resonance energy transfer techniques.
    Busnelli M; Mauri M; Parenti M; Chini B
    Methods Enzymol; 2013; 521():311-27. PubMed ID: 23351747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greatly enhanced detection of a volatile ligand at femtomolar levels using bioluminescence resonance energy transfer (BRET).
    Dacres H; Wang J; Leitch V; Horne I; Anderson AR; Trowell SC
    Biosens Bioelectron; 2011 Nov; 29(1):119-24. PubMed ID: 21873043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
    Keov P; Sexton PM; Christopoulos A
    Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resonance Energy Transfer-Based Approaches to Study GPCRs.
    Ayoub MA
    Methods Cell Biol; 2016; 132():255-92. PubMed ID: 26928548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
    Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
    Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling.
    Lohse MJ; Nuber S; Hoffmann C
    Pharmacol Rev; 2012 Apr; 64(2):299-336. PubMed ID: 22407612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
    Vedel L; Bräuner-Osborne H; Mathiesen JM
    J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization.
    Ayoub MA; Pfleger KD
    Curr Opin Pharmacol; 2010 Feb; 10(1):44-52. PubMed ID: 19897419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based molecular modeling approaches to GPCR oligomerization.
    Kaczor AA; Selent J; Poso A
    Methods Cell Biol; 2013; 117():91-104. PubMed ID: 24143973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New technologies enabling the industrialization of allosteric modulator discovery.
    Lütjens R; Perry B; Schelshorn D; Rocher JP
    Drug Discov Today Technol; 2013; 10(2):e253-60. PubMed ID: 24050276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessment.
    Raddatz R; Schaffhauser H; Marino MJ
    Biochem Pharmacol; 2007 Aug; 74(3):383-91. PubMed ID: 17572390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using quantitative BRET to assess G protein-coupled receptor homo- and heterodimerization.
    Achour L; Kamal M; Jockers R; Marullo S
    Methods Mol Biol; 2011; 756():183-200. PubMed ID: 21870226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors.
    Alvarez-Curto E; Pediani JD; Milligan G
    Anal Bioanal Chem; 2010 Sep; 398(1):167-80. PubMed ID: 20517598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR Allosteric Modulator Discovery.
    Wu Y; Tong J; Ding K; Zhou Q; Zhao S
    Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer.
    James JR; Oliveira MI; Carmo AM; Iaboni A; Davis SJ
    Nat Methods; 2006 Dec; 3(12):1001-6. PubMed ID: 17086179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.